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1 Authors contributed equally.a b s t r a c tMagnetic hyperthermia which exploits the heat generated by magnetic nanoparticles (MNPs) when exposed to
an alternative magnetic field (AMF) is now in clinical trials for the treatment of cancers. However, this thermal
therapy requires a high amount of MNPs in the tumor to be efficient. On the contrary the hot spot local effect
refers to the use of specific temperature profile at the vicinity of nanoparticles for heating with minor to no
long-range effect. This magneto-thermal effect can be exploited as a relevant external stimulus to temporally
and spatially trigger drug release.
In this review, we focus on recent advances in magnetic hyperthermia. Indirect experimental proofs of the local
temperature increase are first discussed leading to a good estimation of the temperature at the surface (from 0.5
to 6 nm) of superparamagnetic NPs. Then we highlight recent studies illustrating the hot-spot effect for drug-
release. Finally, we present another recent strategy to enhance the efficacity of thermal treatment by combining
photothermal therapy with magnetic hyperthermia mediated by magneto-plasmonic nanoplatforms.Keywords:
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Magnetic hyperthermia (MHT) is a type of thermal cancer treatment
that takes advantage of the heat generated by magnetic nanoparticles
(MNPs). MHT has been extensively investigated both theoretically and
experimentally to reach a therapeutic efficacy. Activating the MNPs
located deep inside the tissues or organs by MHT can be accomplished
at frequencies (f) and field (H) conditions that do not harm the
human body (H x f ≤ 5 × 108 A/m.s)[1]
When exposed to alternative magnetic field (AMF) of appropriate
amplitude and frequency, MNPs release heat, which reduces the viabil-
ity of cancer cells through apoptotic or necrotic pathways. Such nano-
thermo-therapy is already in clinical trials (e.g. phase II for glioblastoma
multiforme,MagForce, Berlin, http://www.magforce.de/en/home.html)
and received a European market authorization. [2]
For superparamagnetic MNPs, magnetic loss responsible for
converting magnetic energy into heat under AMF is attributed to
Néel-Brown relaxations. [3] Magnetic heating is attractive as a physical
modality for cancer treatment due to specific features such as
non-invasiveness, no depth penetration limit, remote controllability,
nanoscale spatial resolution, and molecular-level specificity. However,
magnetic hyperthermia still suffers from critical drawbacks, including
the need for a high dose of MNPs (usually 1–2 M, which is a few orders
ofmagnitude larger than contrast agent used forMRI) or therapeutic re-
sistance arising from self-protective mechanisms of cancer cells against
the applied thermal stress.
In recent years, in order to overcome such limitations, new
approaches based onmultimodal synergistic therapy, employing the in-
tegration of two or more form of treatment, were developed. [4]
Multimodal synergistic therapy is defined as the cooperation among
different treatments integrated into a single nanoplatformwhose yields
enhanced therapeutic effects compared to the individual treatments.
The combination ofmultiplemodalities in a single system is possible
thanks to a smart design of multifunctional nanomaterials. The first ap-
proach for multimodal therapy is to combine a physical treatment
(MHT, photothermal therapy (PTT), high intensity focused ultrasound
(HIFU) and others) and a chemotherapy in the same platforms. Numer-
ousmagnetic systemswere designed to trigger drug release byMHTbut
only few of them managed to release the drug by hot spot local effect,
meaning in global athermal conditions.
In this review we will first focus on the heat generated by MNPs at
the nanometer scale to magnetically induce drug release from poly-
meric platform. This local heat delivery and subsequent therapeutic
drug release is complementary to single-handed MHT. Besides, AMF
may provide remote regulation of the amount of drug release, enhance-
ment of the therapeutic effectiveness and decrease of systemic toxicity,
notably through spatial and temporal control of drug release. Second,
we will present another recent strategy to enhance the efficacy of ther-
mal treatment, by combining PTT with MHT, mediated by magneto-
plasmonic nanoplatforms.
2. Magnetic hyperthermia for remotely triggered drug delivery
in athermal conditions
2.1. The hot spot effect
The last 20 years have witnessed an important increase in the num-
ber of reports dedicated to magnetic hyperthermia. Many have focused
on the “hot spot effect” which refers to the use of specific temperature
profile at the vicinity of nanoparticles (nano-assemblies) for heating
with minor to no long-range (macroscopic) effect. Such an approach
has numerous advantages. First, the effect becomes less dependent on
the number of nanoparticles usually required to increase significantly
the macroscopic temperature in the targeted area. Hence, no major
stress is applied to the biological environment, allowing a better recov-
ery of neighboring healthy cells or organs. The toxicity is thus strongly
limited and side-effects of magnetic nanoparticles are dramatically
reduced. Secondly, the thermal profile around the nanoparticles can
induce drug release without thermally damaging the areas of interest.
Once again, side-effects should be limited. Additionally, nanoparticleaggregation, that often occurs in cellular environment and limits the
macroscopic heating efficiency of magnetic nanoparticles, should not
impact the local temperature effect as it impacts the macroscopic
heating efficiency [5–7].
Last, very local effects can be triggered, without damaging other
organelles within the cells. For instance, Huang et al. demonstrated
that nanoparticles targeted to the outer membrane of cells can activate
ions channels with very local temperature increase without thermally
affecting the Golgi apparatus [8].
Hot spot effect requires evidence of the heating efficiency at the local
stage. These proofs could be indirect (evaluation of a thermal effect to a
physical property) or a direct evaluation of the thermal gradient in the
area of interest. Most recent publications elucidate the indirect role of
local heat generation.
Most “hot spot” effects are triggered by thermosensitive reactions.
N'Guyen et al. described a retro-Diels-Alder reaction conducted through
hyperthermia excitation on maghemite nanoparticles functionalized
with multifunctional ligands that use maleimide to link a furan-
terminated moiety as thermosensitive linkers [9]. They evidenced a
fluorophore release proportional to the excitation duration and the
nanoparticles concentration, with no macroscopic temperature in-
crease. The same retro-Diels-Alder reactions were used and monitored
by magnetic hyperthermia on (Zn0.4Mn0.6)Fe2O4 magnetic nanoparti-
cles in mesoporous silica employed as cargo by Rühle et al. [10] The
pores of the cargos were closed with molecules that act as nanovalves
and could liberate the payload by the thermosensitive reaction. This re-
action allowed to control themolecular release above 65 °C, as shown in
Fig. 1. Jaque et al. explored new nanothermometric methods combining
light emission properties of luminescent nanoparticles in the Near-
Infrared (NIR) range with nanoheaters under magnetic field. [11]
The release of fluorescein with AMF stimulation demonstrated that
the surface temperature of the cargos reaches at least 65 °C, about
20 nm apart from the magnetic particle surface.
Thermosensitive block copolymers were also reported for surface
functionalization of magnetic nanoparticles by Polo-Corrales and
Rinaldi [12]. The authors demonstrated that a rapid temperature in-
crease occurs in the immediate vicinity of the nanoparticles while the
macroscopic temperature increases more slowly in the bulk. They con-
cluded that their polymer (PNIPAM) crossed the lower critical solution
temperature (LCST) even though the medium has not reached this crit-
ical value. Very recently graftingmolecularly imprinted polymers (MIP)
on iron oxide nanoparticles was reported by Griffete et al. for drug
delivery applications [13]. The release of doxorubicin was significantly
increased when particles were submitted to the AMF stimulation [13].
The release rate was comparable to the one obtained at temperature
higher than 50 °C, which gave an evaluation of the mean temperature
in the polymer corona around the magnetic core (10–30 nm). More
recently, the direct radical polymerization of the MIP layer through hy-
perthermia excitation at moderate temperature was also evidenced by
the same group [14]. This polymerization usually occurs at 60 °C, but
it could be achieved at temperature below 31 °C undermagnetic activa-
tion, confirming the temperature increase proposed in the previous
work. Similar results were obtained by Guisasola et al. who elaborated
nanocarriers made of iron oxide nanoparticles embedded in a
silica shell loaded with fluorescein and modified with an outer
shell of thermosensitive polymer (NIPAM/NHMA) [15]. In this
nanoarchitecture, despite the fact that the iron oxide core is 20 nm
away from the surface of the carrier, LCST transition was observed
under magnetic stimulation. Moreover, the release of fluorescein was
demonstrated to be more efficient in isothermal condition with mag-
netic stimulation than with macroscopic heating.
Taken together, these results show that local thermal effect could be
of outmost importance for the next generation of magnetic carriers for
therapeutic applications. These systemswill need amore careful charac-
terization and nano-investigations toward specific and controlled
effects.
Fig. 1. Release of the fluorescein cargo from samples (a) Mesoporous silica nanoparticles -cyclodextrine (MSN-CD) and (b) MNP@MSN-CD through (a) bulk solvent heating and (b) local
sheating. Reprinted with permission from [10].
Fig. 2. Comparison of the temperature variation reported by Riedinger et al. [20], Dias et al.
[18], Griffete et al. [14], and N'Guyen 9 Reproduced with permission from ref. [14,18,20,9]
respectively.While the “hot-spot” effect has started to be explored indirectly from
macroscopic observations of nanoscale-derived effects, the direct evalu-
ation at the nanoscale of the local temperature profile around the nano-
particles is less investigated. To reach such information Dong and Zink
used the dependence of fluorescence on up-conversion emission spec-
trum of NaYF4:Yb3+,Er3+ nanoparticles embedded intomesoporous sil-
icamatrix withmagnetic particles [16]. The temperature wasmeasured
in the silica matrix, but without precision on the temperature around
the magnetic nanoparticle. However, compared to bulk where a tem-
perature increase of only 20 °C was observed, the authors distinguished
a more rapid temperature increase, reaching up to 45 °C above the
starting temperature around the nanoparticles. Even though the gradi-
ent of temperaturewas not elucidated exactly at the surface ofmagnetic
nanoparticles, this proof of concept is of prime importance to establish
temperature profile in the vicinity of hot spots.
Alternatively, DNA coupled with fluorophores can be also used as a
local thermometer [17]. Gareau et al. demonstrated that non-
expensive DNA strands could be used with good sensitivity (0.05 °C)
in a large range of temperature (30 °C to 85 °C). They showed that the
combination of thermoswitches allows large gain of fluorescence for
very low temperature variation. This strategy could benefit to the tem-
perature measurement around hot spots. Equivalently, Dias et al. used
the hybridization of DNA to measure precisely the temperature at the
surface of iron oxide nanoparticles [18]. They were able to report varia-
tions of temperature (in comparison to themacroscopic one) of 8.3 °C at
5 nm from the nanoparticle surface to 6.1 °C at 5.6 nm.
Another example on the use of DNA is given by Yu et al. [19]. The au-
thors evaluated the thermodynamic equilibrium between the hybridi-
zation and denaturation of double-stranded DNA. This strategy is less
straightforward because it needs the separation of the unlinked DNA
strands from the bulk dispersion (“rapid” separation is achieved). On
the more, their results depend strongly on the excitation time, and the
temperature increase between the surface of the nanoparticles and
the bulk is reported to be approximatively 50–60 °C, with no direct de-
termination of the exact distance of the DNA from the surface. It is just
stated that the difference in temperature is given “at the surface” com-
pared to the bulk.
Polymers can also be used as spacers between the surface of iron
oxide nanoparticles and a thermo-sensitive linker. Riedinger et al. pre-
pared 15 nm diameter iron oxide nanoparticles coated with polyethyl-
ene glycol (PEG) oligomer terminated by a fluoresceine-amine dye
attached to a thermolabile azo linker [20]. The length of the PEG was
modified from 500 g/mol to 1500 g/mol, and 8000 g/mol. These molec-
ular weights allowed to reach different distances from the surface of the
nanoparticle: 0.47 nm, 0.83 nm, and 1.9 nm. The temperature increases(above the bulk temperature) measured at those distances are 42 °C,
26 °C, and 11 °C, respectively. In this example, the distances are closer
to the surface of the particles, compared to the work of Dias et al. who
recorded the temperature at 5–6 nm from the surface.
These nanoparticleswere not synthesized by the samemethod, have
different sizes, and different magnetic excitation parameters (magnetic
field amplitudes and frequencies). However, all results collapse to a
unique image showing a strong thermal gradient from the surface of
the nanoparticles to the surrounding medium (Fig. 2). A unique study
combining short and large distance measurements on the same system
is still missing. Interestingly, in another study made in our group, with
another system involving AMF-mediated thermo-polymerization at
the surface of MNPs, the extrapolation of the temperature profile, yet
less resolved, is in good agreement with the reported data of Fig. 2.
Finally, we must emphasize that, while MHT has been extensively
studied for thermal therapy and drug delivery, exploring the “hot-
spot” effect is still in its infancy. Hybrid materials combining a magnetic
and a polymeric component (thermoresponsive, molecularly
imprinted) have shown to be very promising for local heating applica-
tions in drug delivery and hyperthermia therapy and will be reviewed
thoroughly in the following sections of this paper.
2.2. Magnetic thermoresponsive polymeric nanosystems
In the last few years, triggered drug delivery, especially using AMF
[21], attracted a lot of attention. Magnetic mesoporous silica nanoparti-
cles were the main focus of numerous studies, as they are a promising
platform for cancer therapy [22] due to their potential in chemothera-
peutic drug delivery and hyperthermia therapy under an AMF. For ex-
ample, Ruiz-Hernandez et al. synthesized γ-Fe2O3/mesoporous silica
microspheres, and found that these magnetic microspheres showed a
sustained drug release behavior and ability to generate heat under a
low-frequency AMF [23]. Alternatively Lu et al. reported the preparation
of 100 nmmagnetic hollow mesoporous silica nanocapsules, and these
nanocapsules showed magnetic field induced heating and remotely
triggered drug release capabilities, which is promising for the combina-
tion of hyperthermia and chemotherapy [24]. The applications of silica-
based nanomaterials in drug delivery and nanotherapy applications
have been reviewed elsewhere [25,26], herein wewill only focus on or-
ganic polymer basedmaterials asmicro- and nano-gels andmolecularly
imprinted polymer which, when combined with MNPs, offer intriguing
opportunities regarding the development of a novel class of
nanomaterials for drug delivery.
Due to their versatile macromolecular structures, polymers can
serve asflexible nanoplatforms. A large portfolio of polymerswith inter-
esting physico-chemical properties have been developed with a special
focus on those that exhibit structural or conformational changes in re-
sponse to different stimuli. The release of drug can be achieved either
by local biological stimuli (pH, redox, enzymes) or by externally applied
radiation (light/electromagnetic fields, focused ultrasound). However
biological environments offer no possibility of remote activation or
dose control over drug release, contrary to external triggerswhich pres-
ent advantages to achieve drug release with spatiotemporal and/or on
demand control.
A highly comprehensive review dealing with the remote release
by AMF of different drug delivery nanoplatforms (liposomes,
polymersomes, capsules) has been published elsewhere [27]. Local
drug delivery controlled by an external stimulus using nanoparticulate
systems has emerged as a very promising strategy for nanomedicine.
However, this requires a specific and well-controlled design.2.2.1. Synthesis of thermosensitive magnetic micro and nanogels
Thermosensitive magnetic micro and nanogels are crosslinked poly-
mer networks, capable of absorbing large quantities of drugs and water
in the swelling state, and containingmagnetic nanoparticles, that can be
heated when exposed to an alternative magnetic field. In any case, the
drug release is activated by an AMF-generated local heating (at nm-
scale) whichmay bemutualized with magnetic hyperthermia if macro-
scopic temperature elevation reaches a threshold, typically 43 °C. In
other words, magnetically induced drug release can occur in the local
“hot spot” condition without macroscopic temperature elevation.
Thermosensitive magnetic micro- or nanogels are typically made of
thermosensitive, hydrophilic and functional polymers, which can be
physically or chemically crosslinked to form a gel network and present-
ing a volume phase transition temperature (VPTT) or a LCST. The local
temperature can generate the swelling-deswelling transition of the
nanogels, thus remotely trigger drug release.
Among these functional polymers, Poly(N-isopropylacrylamide)
(PNIPAm) is considered a gold standard material for preparing
thermoresponsive nanodevices. Despite its low LCST (32 °C) the tem-
perature can be easily tuned above 37 °C by simply copolymerizing
NIPAm with more hydrophilic monomers.
Magnetic micro or nanogels can be classified according to the nature
of the interaction between the MNPs and the polymer chains (covalent
or hydrogen bonds), themorphology of the gel (core or core@shell) and
the distribution of MNPs within the polymer matrix (inside or at the
surface of the matrix). For their synthesis, MNPs can be introducedbefore or after the polymerization step; or can be synthesized in situ
in the nanogels' matrix.
Kondo et al. synthesized magnetic nanogels of PNIPAm by adding
Fe3O4 NPs before the polymerization process. To allow the dispersion
of the Fe3O4 NPs, the authors synthesized a polystyrene shell (PS)
around the NPs. This shell also allows to interact with growing PNIPAm
chains and to aid polymerization around theMNPs [28]. Nevertheless, it
is neither possible to control the diameter of the nanogels (100 to
400 nm), nor the quantity of incorporated MNPs (5–20% by mass)
using this method [28,29]. Recently, the effect of NPs stabilization on
the synthesis of Fe3O4/PNIPAm hybrid nanogels has been studied by
Jaiswal et al. [30]. In this study, different ligands (citric acid, ethylene di-
amine, chitosan) were used. The authors showed that the mass ratio in
NPs (%) inside the nanogels is increased, up to 40%, by stabilizingMNPs
in the solution during the polymerization reaction. Using thismethod, it
is possible to develop hybrid nanogels in a single step. However, it is
very difficult to control the physico-chemical properties of nanogels
(size, polydispersity, distribution of NPs within the polymer matrix),
aswell as the amount ofMNPs incorporated into thematrix. In addition,
the polymerization of the monomers in the presence of MNPs tends to
form a core-shell structure, with a core containing mainly MNPs and a
shell composed essentially of polymer.
Otherwise, Kumacheva et al. synthesized pH- and thermosensitive
hybrid PNIPAm nanogels functionalized with acrylic acid (AA), by
forming in situ the iron oxide NPs in the polymer matrix [31]. In the
same way, Kawaguchi et al. used functionalized PNIPAm nanogels
with glycidyl methacrylate (GMA) groups, to prepare the MNPs inside
the polymer matrix [32–34]. The incorporation of GMA groups is very
interesting because these groups can be modified after polymerization
to introduce various active functions, such as amine, carboxylate and
sulfonate, by post-modification with thiol compounds.
Furthermore, the synthesis of magnetic nanogels can be carried out
by a post-synthesis assembly of thermosensitive nanogels and inorganic
MNPs. The constituents (nanogels and MNPs) are synthesized sepa-
rately before being assembled by electrostatic interactions, by formation
of complexes or by covalent bonds between nanogels and MNPs. In this
way, Pichot et al. prepared negatively charged MNPs coated with so-
dium citrate and positively charged nanogels functionalized with
amine groups [35,36]. The assembly of these objects takes place at
pH 7.0, however if the pH ismodified, the desorption of NPs is observed.
One advantage of post-assembly process is that it allows the tuning of
the magnetic and thermoresponsive properties of individual compo-
nents (nanoparticles and microgels) separately before assembling
them.
Huge efforts were dedicated to the synthesis of these magnetic-
thermoresponsive polymers platforms. However their heat responsive-
ness was often tested by using a water bath rather than AMF.
2.2.2. Drug delivery under AMF
PNIPAm magnetic microgels were prepared by R. Regmi et al. by
adding Fe3O4 nanoparticles inside the polymericmatrix after the radical
polymerization of microgels [37]. These nanogels have a LCST around
38 °C and show substantial heating, reaching 50 °C in only 4 min, and
releasing 1% of the drug (mitoxantrone) per minute, when exposed to
an AMF (380 kHz; 10.3 kA.m−1).
M. Jaiswal and co-workers also prepared PNIPAm magnetic
nanogels, but Fe3O4 nanoparticles were entrapped in the polymer ma-
trix during the polymerization process [38]. These nanogels (hydrody-
namic diameter 200 nm) have a LCST of 40 °C and are able to induce a
two-fold increase of the drug release (doxorubicin) under AMF
(5 kW, 230 kHz, 1 h) without macroscopic heating. These nanogels in-
duced a cell death of 80% after 1 h of AMF (HeLa cells). J. Wong
and co-workers prepared microgels by a layer-by-layer assembly of
polyelectrolytes (adding successively positively charged poly
(diallyldimethylammonium chloride) (PDADMAC) and negatively
charged poly(acrylic acid) in order to facilitate the deposition of
MNPs at the surface of PNIPAm nanogels [39]. The as prepared nanogels
(dh = 190 nm, LCST around 32 °C) are able to heat above 50 °C in b30 s
when applying an AMF (360 kHz, 20 kA.m−1). Thus, the magnetic shell
generates enough heat to provoke the deswelling of the PNIPAm core.
Although the NIPAm monomer is highly cytotoxic, it has been
shown in the literature that the cytotoxicity of the PNIPAm polymer is
less or even zero. However, after several purification steps, the PNIPAm
crosslinked matrices may still contain monomers, making the system
toxic [40,41]. In addition, PNIPAm can also interact with human body
proteins due to the presence of several amide functions in its chemical
structure [42]. Thus, it is very difficult to use this polymer for biomedical
applications. Otherwise, some natural polymers, such as alginate, have
also been used for designing biocompatible magnetic microgels. C.
Ménager et al. [43] prepared magnetic alginate microbeads by micro-
emulsion polymerization and loaded with doxorubicin (DOX) and
γ-Fe2O3 NPs. DOX released was enhanced from these nanogels, from
25.9 μg.mL−1 (water bath at 37 °C) to 60 μg.mL−1, by applying an
AMF (700 kHz, 26 mT, 2 h).
Recently, magnetic nanogels based on biocompatible, water-soluble
and non-toxic monomers derived from oligo (ethylene glycol methyl
ether methacrylate) monomers (OEGMAs) have been synthesized
[44–46]. Cazares-Cortes et al. synthesized pH and thermoresponsive
OEGMAs-nanogels by conventional precipitation radical copolymeriza-
tion in water and post-assembled by complexation with γ-Fe2O3 NPs
[47]. This method provides monodisperse nanogels with a high content
of homogeneously distributedmagnetic nanoparticles. Themass ratio of
loaded MNPs inside nanogels can be tuned from 9.0 to 37.5 wt%
(Fig. 3a). Biocompatible nanogels (hydrodynamic diameter from 328
to 460 nm, LCST = 47 °C at pH 7.5), containing 37.5 wt% MNPs, have a
high drug loading efficiency (63%). The release of doxorubicin (DOX)
from the nanogels can reach 47% at pH 7.5 under AMF (24% without
AMF) in athermal conditions. Here, magnetic nanoparticles act as indi-
vidual nanoheaters or “hot-spots”. They generate a localized heating,
without raising the global temperature of themedia. The heat is enough
to provoke the phase transition of the polymers chains. Interestingly, it
was demonstrated that these nanogels are excellent nanocarriers for
enhancing the internalization of DOX inside PC-3 cancer cells and that
it is possible to trigger intracellularly and remotely DOX release under
AMF (335 kHz, 12 A.m−1), thus enhancing DOX efficiency in terms of
cytotoxicity. Cancer cell viability was reduced from 51 to 32% in theFig. 3. a) TEM images of thermoresponsive OEGMAs-nanogels (MagNanoGels) loadedwith 9 an
cells) incubated for 2 hwith free DOX,MagNanoGels, and DOX−MagNanoGels with andwitho
mT, 14.4 kA·m−1). The x-axis of iron concentration [Fe] from 0.5 to 4.2 mM corresponds to
Reproduced with permission from ref. [47]. Copyright 2017 the American Chemical Society.presence of DOX-nanogels and (DOX-nanogels+AMF), respectively
(Fig. 3b).
Multi-responsive nanogels, combining two or more stimuli, are use-
ful for treating diseases characterized by the variation of an internal pa-
rameter (temperature, pH, redox composition). For example, anticancer
therapies must be improved by using nanocarriers sensitive to both
acidic media and AMF. Indeed, the pH variation between the physiolog-
ical environment of normal cells (pH 7.5) and cancer cells (pH 4.5–6.5)
would enhance drug release inside cancer cells [48–50]. In addition,
using an AMF as external stimulus may provide regulation of the
amount of drug released, enhancement of the therapeutic effectiveness
and decrease of systemic toxicity, notably through spatial and temporal
control of drug release.
2.2.3. In vivo drug release under AMF
Despite the large portfolio of thermoresponsive nanosystems tested
in vitro, only few studies have demonstrated the efficacy of AMF for
in vivo drug release. [51,52]
Injectable hydrogel that undergoes a gelation process at 37 °C, keep-
ing the MNPs at the tumor site and causing a heat mediated release of
encapsulated necrotic factors was developed. MNP were also clustered
inside a poly(pyrrole carboxylic acid) exhibiting a glass transition at
44 °C and loaded with DOX. The material injected intratumorally was
able to cause complete tumor suppression due to the dual MHT heat
(44 °C) and chemotherapeutic effect [53].
Efficient drug releasing magnetic polymeric NPs for anti-epileptic
applications, based on thermosensitive PEO-PPO-PEO(F127) triblock
copolymer nanogels bound with PVA and loaded both with magnetic
NPs and ethosuximide (ETX), a calcium channel blocker for anti-
epilepsy applications were recently developed [54]. After intravenous
injection and magnetic targeting of the NPs toward the rat brain, the
reduction of epileptic episodes measured by electrophysiological
recording was demonstrated through the decrease of the spike-wave
discharges (SWD) over 2 h, upon the AMF-induced (2.5 kAm−1,
44.2 kHz, 15 s) burst release of ETX (Groupe I)whereas free ETX admin-
istered (1 h, Groupe III) or ETX-loaded PVA (Groupe II) nanogels were
shown not efficient (Fig. 4a).
Injectable, biodegradable and thermosensitive TRAIL/SPION (tumor
necrosis factor-related apoptosis-inducing ligand/superparamagnetic
iron oxide nanoparticle) nanocomplex hydrogels (T/S-NH) were usedd 37.5wt%MNPs (a1, a2 respectively). b) Cell viability of PC-3 cells (normalized by control
ut an AMF (an AMFwas applied 2 h after the end of incubation, and for 2 h, at 471 kHz, 18
an equivalent DOX concentration [DOX] from 4 to 32 μM for the DOX − MagNanoGels.
Fig. 4. a) Comparison of the mean number of SWDs for a 1 h period within Group I, Group II, and Group III pre-AMF and post-AMF treatment. **p b .01 statistically significant decreases
were present when pre-AMF was compared to post-AMF in Group I. b) In vivo therapeutic outcomes of either single or combination therapy. The tumor volume (V/Vinital) is plotted
versus time after treatment. The arrow indicates the day of MHT. The symbol ** indicates the statistical significance at levels of P b .01 and *** indicates P b .001.in combination with mild multiple MHT and MHT-mediated TRAIL
release, with the aim of killing TRAIL-resistant glioblastomamultiforme
cells [55]. Hyperthermia can enhance the release of TRAIL from
hydrogels through temperature-sensitive hydrogel dissolution. TRAIL-
resistant U-87 MG cells were killed by the combination of TRAIL and
multiple hyperthermia via caspase-3 and -8 active apoptosis. The
hyperthermia enhanced cytotoxicity of TRAIL was dependent on the
hyperthermia cycle number and corresponding TRAIL release. Signifi-
cant in vivo tumor reduction was observed by combining 2 cycles of
mild MHT and TRAIL release using a single injection of TRAIL/SPION
nanocomplex hydrogels without damage to main organs (Fig. 4b).
2.3. Molecularly imprinted polymer
Whenmolecularly imprinted polymers (MIPs), a templating process
at themolecular level, were first described several decades ago [56–58],
they were mostly used as separation materials in analytical chemistry.
MIPs are prepared in presence of a template that serves as a mold for
the formation of template complementary binding sites. The resulting
molecularly imprintedpolymers are beingused in awide range of appli-
cations, such as chiral separation [58,59], chemical sensing [60,61], com-
petitive drug assays [62], chemical catalysis [63], or solid phase
extraction [64,65]. MIP synthesis is reproducible, fast and economic.
They are physically and chemically very stable, they are not easily
degraded by proteases or denatured by solvents, and they can be
engineered and tailored for a given application. In principle, MIP can
be obtained for any target, even when no natural receptor or antibody
exists.
Furthermore, the advantage of such a system is the possibility to
integrate a drug inside the polymer and regulate the drug release by in-
creasing the residence time of the therapeutic agent within the poly-
meric matrix, by means of either covalent or non-covalent interactions
in specific binding sites. In this context, a new potential application of
MIP in controlled drug release has attracted considerable attention
[66–70]. Although imprinted drug delivery systems have not reached
clinical application yet, this technology has an enormous potential for
creating satisfactory dosage forms. Several works have been reported
to prepareMIPs with different morphologies as delivery carriers to con-
trol release of drugs, such as monoliths, granules, membranes and
microspheres [71–74]. However, the best shape of MIPs may be the
spherical one due to their excellent isotropic release capacity [75].
Since the surface area per unit volume of a material is inversely propor-
tional to the size of the material, nanosize MIPs have enormous bindingcapacity. The small size of nanoparticles also enables those materials to
be considered for therapeutic applications such as injection into the
blood stream of living animals. In 2010, K. Shea et al. proposedmolecu-
lar imprints in polymer nanoparticles for the toxic peptide melittin, the
main component of bee venom. They created artificial antibodies that
can be used for the in vivo capture and neutralization of melittin [76].
They showed that polymer particles are compatible with the aqueous
environment in living organisms, have readily accessible binding sites
for the target, and are able, like real antibodies, to neutralize its toxic
effect.
It is only recently that novel stimuli such as UV illumination or AMF
were employed for drug release from MIP. For example, asymmetric
MIP particles (Janus particles) synthesized via a wax−water Pickering
emulsion were suggested as self-propelled transporters for controlled
drug delivery [77]. Release of the drug from the Janus MIP particles
can be controlled by switching on−off the UV illumination. But this sys-
tem lacks biocompatibility due to the use of AgNPs and the limitation of
UV illumination which damages cells. Therefore, there is a demand of
adjustment for practical applications.
Concerning the magnetic MIPs, they have emerged as powerful
materials for controlled drug delivery systems because they can be lo-
calized to the pre-delivery sites and release the drug to particular sites
by the external magnetic field [78]. Hence, nanospherical magnetic
MIPs should be suitable as an ideal polymer material for wider applica-
tions. Nonetheless, few studies have been reported on the preparation
of nanospherical magnetic MIPs [79,80] and only five studies have
been reported about the controlled release of drugs by nanospherical
magnetic MIPs. It is only in 2015 that Griffete et al. [81] developed an
innovativemagnetic delivery nanomaterial for triggered cancer therapy
showing active control over drug release by using an alternative mag-
netic field. The material, which combines the controlled drug release
ability of non-thermosensitive MIPs with magnetic properties of iron
oxide, allows the controlled release of doxorubicin. UponAMF exposure,
the hydrogen bonds between the MIP and the DOX are broken and the
molecule is released without any significant heating of the medium.
This strategy is efficient for in cells experiments (Fig. 5). These
nanomaterials offer great promise for the doxorubicin release under a
magnetic field and moreover we think that this approach will be easily
expanded to other polymers, targeting molecules or drugs. The use of
MIP for drug delivery under an alternative magnetic field is a major ad-
vance in the development of multifunctional targeted drug delivery
nanotechnologies and may become an important theranostic tool in
nanomedicine.
Fig. 5. (A,B) Cancer cells (PC-3) internalization of the γ-Fe2O3@DOX-MIPnanoparticles (2 h incubation at [Fe] = 2 mM). DOX is detected in the green channel (excitation at 488 nm,
emission at 561 nm). Nuclei and cell membranes are stained by DAPI (A) in blue and PKH26 (A, B) in red, respectively. Z reconstructions (B) identify DOX inside the cells. (C) Viability
of cancer cells labelled with γ-Fe2O3@DOX-MIP after exposure to the alternative magnetic field R1–2 (AMF at 700 kHz, 25 mT) for 0 min (no AMF), 30 min, 1 h 30 min, and 2 h
30 min compared to the control experiment (cancer cells labelled with γ-Fe2O3 nanoparticles, at the same cellular iron dose, and exposed to the same conditions of AMF). The overall
temperature during treatment was 37.5 °C for both conditions. (D) Treatment of the cancer cells with free doxorubicin (DOX) incubated for 2 h from 0.5 to 50 μM. Cell viability
(normalized by control cells) was measured 24 h after the incubation, in the exact same conditions as the ones used for γ-Fe2O3@DOX-MIP after AMF treatment. Reproduced with
permission from ref. [81]. Copyright 2015 Royal Society of Chemistry.The list of reports dealingwith the elaboration ofmagnetic and poly-
meric nanosystems for drug release under an AMF are summarized in
Table 1.
3. Increasing the heat delivered per nanoparticles
As discussed previously, compared to other physical stimuli, MHT is
an attractive physical modality for biomedical applications such as drug
delivery and thermal therapy. However, despite such advantages, MHT
is still facing some limitations related to the fact that the used
superparamagnetic MNPs suffer from relatively low heat-generating
efficiency. Given the limit of allowed magnetic field strength for living
organs and the injectable dosage of MNPs there is a strong need for
the development of NPs with optimized heating efficiency to achieve
the necessary application. The most investigated strategy is based on
modulation of the design of the MNPs to improve heat generation. In
such direction several groups reported on the synthesis of MNPsTable 1
Magnetic and polymeric nanosystems for drug release under an alternative magnetic field (AM
Nanostructure type Componentsa Bio conditions AM
Core@shell
magnetic nanocubes coated
with polymer
(200 nm)
γ-Fe2O3 (20 nm)
PNIPAM-co-PEGMA
– 22
core@shell microgels
(190 nm)
Fe3O4
PNIPAM + layer-by-layer
PDADMAC and PAA
– AM
36
Magnetic nanogels
(250–450 nm)
γ-Fe2O3 (11.5 nm)
P(OEGMAs-co-MAA)
In vitro PC-3 cells 33
(4
Magnetic nanogels (200 nm) Fe3O4 (12 nm)
PNIPAM
In vitro HeLa cells 23
1 h
Magnetic MIPs (57 nm) Poly(acrylamide-co-acrylic acid) In vitro PC-3 cells A 7
Magnetic microgels Fe3O4
PNIPAM
– 38
Nanocomplexe hydrogels
(400 nm)
Zn0.47Mn0.53Fe2O4 (18 nm)
PZC
In vivo BALB/c
nude mice
36
(2
a PNIPAM: poly(N-isopropylacrylamide)/PDADMAC: poly(diallyldimethylammonium chlori
OEGMAs: oligo-(ethylene glycol)methyl ethermethacrylatemonomers /PZC: poly(organophos
ligand (TRAIL).where the magnetization and/or the anisotropy and/or the size have
been modulated to enhance the Specific Absorption Rate (SAR).
Comprehensive reviews on the recent advances for magneto-thermal
capabilities of nanoparticles dealingwith design principles and biomed-
ical applications have been recently published [85–88]. Another engi-
neering alternative is based on the design of nanocombined inorganic
based therapies including several components which can be physically
and remotely stimulated and can develop synergistic properties.
Magnetoplasmonic nanoplatforms combining the advantages of MHT
and PTT are one of the most recent strategies and will be developed in
this section.
3.1. Magnetoplasmonic NPs
If MNPs are the best candidate for applications in hyperthermia, the
last 20 years have witnessed an increase in the number of publications
showing the efficiency of plasmonic materials as powerful thermalF).
F Modality ΔT Drug
encapsulationa
Drug release Reference
0 kHz; 20 k.A.m−1 25 to 80 °C in
15 min
DOX
0.67 g /g Fe
3 10−1 mg/mL
(4 h)
at 80 °C
[82]
F
0 kHz, 20 kA.m−1
N50 °C in less
than 30s
– – [39]
5 kHz; 12 A.m−1,
x30min)
37 °C
athermal
conditions
DOX
15 mg/g
carrier
100% at pH 5 [83]
0 kHz; 30 kA.m−1; 40 °C DOX
6 μg/mg
carrier
8,4.10−3
mg/mL
[79]
00 kHz; 25mT 37 °C
Athermal
conditions
DOX
6,5 μg/mL
3,26.10−3
mg/mL
[13]
0 kHz;10.3 kA.m−1 50 °C in 4 min Mitoxantrone
(not
indicated)
1% of drug/min [37]
6 kHz; 13.3 kA.m−1
× 60 min)
43 °C TRAIL
20 μg/g
sample
80% release in
20 days
[84]
de)/PAA: poly(acrylic acid)/PEGMA: co-polyethylene glycolmethyl ether acrylate /
phazene)MIPs: DOX:Doxorubicin/ TRAIL Tumor necrosis factor related apoptosis inducing
agents for applications in cancer therapy and drug delivery. Plasmonic
nanoparticles such as gold (Au) and silver (Ag), have fascinating physi-
cal, chemical and optical properties resulting from the spatial confine-
ment of the electrons at the nano-scale. When the wavelength of an
incoming light applied on the surface of metallic nanoparticles is
much larger than the nanoparticle size, its electron cloud will resonate.
The electrons of the nanoparticle will collectively oscillate in the con-
duction band in resonance with the light's frequency [89] . As a result,
the electron cloud is displaced relative to the nuclei, so the surface re-
mains charged positively where the cloud is lacking electrons and neg-
atively where they are concentrated [90] (Fig. 6). This collective
oscillation of all the electrons is called plasmon band, in contrast to
bulk materials, where electrons are not allowed to travel through the
material [91]. The excitation phenomenon on the metal nanoparticle
surface is called localized surface plasmon resonance (LSPR).
The LSPR has twomain characteristics: an enhancement of the elec-
tric field near the particles' surface (which is higher at the surface and
become lower with distance) and a maximum optical extinction at the
plasmon resonance frequency [92]. The shape, the size and the sur-
rounding medium [93–97] are all parameters that can affect the LSPR.
Consequently the synthesis of plasmonic materials can be modulated
to obtain optical responses in the near infrared window where light
scattering effects are minimized by tissues, thus suitable for biomedical
applications [98–101]. Amongplasmonicmaterials Au nanoparticles are
the most used and reported probably because of their high biocompat-
ibility, chemical stability and the rich surface chemistry of Au which
make thempowerful nanoplatforms for biomedical applications. Conse-
quently, this section of the review will first focus on gold based
magnetoplasmonics. For applications in the biomedical field, numerous
morphologies with suitable LSPR have been elaborated including gold
nanorods [102], truncated octahedral [103], nano-pearl necklaces
[104], nanostars [105], nanoeggs [106], nanoflowers [107]. Their optical
properties allowed their applications as biosensors, contrast agents or in
surface enhanced Raman spectroscopy [108–112]. Moreover due to
their high total extinction coefficients and their capacity to convert
into heat the strong absorption of light, gold nanoparticles are more ef-
ficient in photothermia than magnetic particles in MHT, and largely
used for applications in cancer therapy or in drug delivery [113–115].
Besides, gold nanoparticles could overcome some of the challenges
faced by MHT, including the low heat yield generated/ MNP and the
low chemical stability of iron oxides in the intracellular environment
[116]. However, MHT still offers numerous advantages such as no
depth limitations in tissues,magneticmanipulation and targeting. Com-
bining both materials into one single nanohybrid through the elabora-
tion of optimized multifunctional magnetoplasmonic nanoplatforms
may allow not only to inherit from the two components excellent sur-
face chemistry, special optical properties, and superparamagnetic prop-
erties but also to hurdle some limitations of MHT through the
development of synergies resulting from their association.
3.1.1. Synthesis of magnetoplasmonic nanohybrids
To design such magnetoplasmonic multicomponent hybrid nano-
particles, self-assembly or molecular bottom up approaches can beFig. 6. Schematic drawing of the interaction of an electromagnetic radiation with a metal nanused and their synthesis have been very recently reviewed elsewhere
[117]. The resulting nanohybrids can be summarized into three main
designs (Fig. 7): particles embedded into a biocompatible polymer or
silica compartment, core/shell materials, or heterodimeric structures
[109,118], which both can be obtained through the seed growth
strategy.
Among such structures, the magnetoplasmonic core@shell ones are
themost widely reportedmorphologies in the literature. This is because
core/shell structures are easily tunable as their size and shape can be tai-
lored to reach higher control over their optical and physical properties.
The shell layer protects the core from oxidation and enhance stability
and biocompatibility [109,126] but also permits further surface
functionalization [127–129]. Depending on the structure of the coating
layer, core/satellite nanoparticles, characterized by a single core with
the attachment of numerous smaller nanoparticles can be distinguished
from core/shell nanoparticles, which possess fully covered surface due
to shell coating [109,130]. Focusing on the synthesis of this type of
nanoparticles, different chemical and physical approaches have been
proposed to prepare them. However, the most used one is the chemical
deposition process, which consists in the direct deposition of seeds on
already prepared cores followed by a controlled growth of the seeds
to form amore or less continuous coating around them [118]. Referring
to the nature of the core, two types of magnetoplasmonic nanoparticles
can be distinguished: those with a single or multiple magnetic core,
mainly magnetite or maghemite which have been deeply investigated
and successfully synthesized, and nanoparticles having a plasmonic
core, usually formed by silver or gold metals [109,118]. Incorporating
the plasmonic component inside the magnetic shell represents a syn-
thetic challenge as the difference in the surface energies could give
rise to the segregation of the plasmonic and magnetic component
[131]. Moreover the optical and physical properties of the plasmonic
part can be inactivated in such structure [132,133].
3.1.2. Magnetoplasmonic Fe3O4@au for thermal therapies
Concerning the applications of magnetoplasmonic nanohybrids as
nanothermal agents, although different architectures have been
reported (Table 2) surprisingly and in majority only the plasmonic
part has been investigated for hyperthermia applications. The iron
oxide component has been mainly used as a MRI agent or for magnetic
manipulation and targeting [128,134–137]. Fan et al. [138] developed
S6 aptamer-conjugated magnetic core plasmonic shell nanoparticles
for the targeted diagnosis, isolation, and photothermal destruction of
SK-BR-3 human cancer cells. During the photothermal destruction of
SK-BR-3 cancerous cells bound to S6 aptamer-conjugated magnetic/
plasmonic nanoparticles, the localized heating that occurs due to the
absorption of 670 nm continuous NIR irradiation is able to cause irrepa-
rable cellular damage; it selectively kills most of the cancerous cells
within 10 min at 2.5 W/cm2. Very recently Li et al. [139] developed a
kind of bioeliminable magnetoplasmonic nanoassembly for
photothermal cancer therapy under the guidance of trimodal imaging
of computer tomography (CT), photoacoustic tomography (PAT) and
MRI. A single dose of photothermal therapy under near-infrared light
induced a complete tumor regression in mice. The idea of designingosphere. A dipole is induced, which oscillates with the electric field of the incoming light.
Fig. 7. TEM images of three types of magnetoplasmonic nanoparticles: Type I, spherical core/shell, core-satellite and non-spherical core/shell nanoparticles (a) Fe3O4@Au core/shell.
Reproduced with permission from ref. [119] (b) Au coated iron oxide. Reproduced with permission from ref [120] (c) Fe3O4@Au Nanocube. Reproduced with permission from ref.
[121]; Type II, heterodimer nanoparticles (d) Fe3O4@Au nanocomposites. Reproduced with permission from ref. [122] (e and f) water soluble Au-PEG-Fe3O4 conjugated NPs.
Reproduced with permission from ref. [123]; Type III, multicomponent hybrid nanoparticles (g) γ-Fe2O3@SiO2@Au NPs. Reproduced with permission from ref. [124] (h) Fe3O4-Au /
pSiO2 core/shell NPs. Reproduced with permission from ref. [125].optimized magnetoplasmonic nanoplatforms for applications in com-
bined bimodal magnetic hyperthermia and plasmonic photothermia is
very recent. In 2013 Abdulla-Al-Mamun and collaborators proposed
core@shell nanostructures formed by magnetic nanocubes and a gold
ultrathin layer for hyperthermia-photothermal activity. [121] Themag-
netic core of the nanoheaters was prepared by a colloidal method and
the gold shell was synthesized by seed growth. It was demonstrated
under the simultaneously combined magnetic field and
photoirradiation with Fe3O4@Au a much higher HeLa cells killing than
when both external stimuli are applied separately (Fig. 8.I).
In 2015 an optimizedmagnetoplasmonic core/shell structure associ-
ating a magnetic nanoflower core optimized for MHT and a multi-
branched gold shell optimized for photothermia was designed by ourTable 2
Magnetoplasmonic MNP@Au nanostructures and their applications in PTT and combined MHT
Nanostructure type Components Bio conditions Modality ΔT
Multicore@shell Fe 3O4 & Au HepG2 cells
In vivo
Mono 80
Core@core@shell Fe 3O4 & SiO2 & Au HepG2 cells Mono 80
Multicore@shell Fe 3O4 & Au PC3 cells Mono 68
Dumbbell like Fe 3O4 & Au SW1222 colorectal cells Mono 80
Core@shell Fe 3O4 & Au & SiO2 SKBR3 cells Mono 80
Core@shell Fe3O4@P(St/MAA)@
Chitosan@Au
L929 cells
HepG2 cells
Mono 80
Core@shell Fe 3O4 & Au & S6 SK-BR-3 cells Mono 67
Core@shell Fe 3O4 & Au HeLa cells Mono 80
Core@shell Fe 3O4 & Au HeLa cells Dual 35
Multicore@shell
Fe 3O4 & Au In vivo Dual 68
Core@shell Fe 3O4 & Au-C225 U251 cells
in vivo
Mono 63group [139]. Once again, the aim is to overcome the limitations of mag-
netic hyperthemia byphotothermiawhile allowingmagneticmanipula-
tion and targeting. The versatility of the system in generating heat
through a remarkable cumulative effect when both magnetic and plas-
monic modalities were applied simultaneously was demonstrated and
showed for the first time that the heating efficiency was maintained
under in vivo conditions. The tumor temperature can then rapidly
reach 48 °C, a condition for therapeutic tumor ablation, with a dose
injected 10 times lower than that for classical MHT treatment (Fig. 8.
II). Besides, such core/shell structure brings the additional advantage
of providing the hybrid with a biostability overcoming the one of
MNPs alone, and thus maintaining the thermal efficiency on the long-
term, in the intracellular environment [141]. More recently Lu et al.+ PTT.
Reference
8 nm 0.7 and 1 W/cm2 10 min → 37 °C [139]
8 nm 2 W/cm2 10 min → 40 °C [137]
0 nm 0.3 W/cm2 → 10-12 °C [143]
8 nm 5 W/cm2 10 min → 29 °C [144]
8 nm 3.72 W/cm2 10 min → live/dead stain [145]
8 nm 1 W/cm2 10 min → cell viability assays [146]
0 nm 2.5 W/cm2 20 min → up to 55 °C [140]
8 nm 1.6 W/cm2 15 min→ cell viability assays [147]
0-800 nm 3 mW/cm2 and 560 kHz 7V 0.8A 5 min → cell viability assays [121]
0 nm 0.3 W/cm2 and 110 kHz 25mT 2 min → 20 °C [143]
5 nm 0.3 W/cm2 and 230 kHz 30A → cell viability assays [142]
Fig. 8. I) (Up) Surviving fractions of HeLa cells incubated in MEMmedia containing (a) Fe3O4, (b) Fe3O4@Au nanocubes with cells under both AMF and photoirradiation only 5 min. (Down) Comparative temperature increment of MEM containing
(a) Fe3O4 and (b) Fe3O4@AuwithHeLa cells, and (c) onlyMEMunder combinedmagnetic field and photoirradiation for cell killing application. Reproducedwith permission from ref. [131] II) (Up) Typical infrared thermal imaging pictures after 5min
heating underMHT alone, PLASM alone and bimodalMHT+PLASM. (Down) Typical temperature elevation profiles of the injected (T+) and non-injected tumours (T−, control tumor) as a function of time for the three treatments. Reproducedwith
permission from ref. [132] III) (Up) Proliferation of U251 glioma cells after different treatments. (Down) Heat generation by Fe3O4@Au-C225 MNPs in suspension after applied AMF combined with NIR. Reproduced with permission from ref. [133].
[142] have developed another magnetoplasmonic therapeutic platform
for tumor therapy based on Fe3O4@Au-C225 composite-targeted MNPs.
The drug C225 was physically adsorbed to the surface of Fe3O4@Au-
C225 MNPs. Furthermore, the dual magnetic and photothermal action
mediated by Fe3O4@Au-C225 composite-targeted MNPs resulted in in-
trinsic apoptosis of U251 cells in vitro and growth suppression of
tumor in vivo, which showed remarkable improvement in synergistic
therapeutic effects for glioma treatment (Fig. 8.III).
4. Conclusion and outlook
Despite the recent progress in heat generating MNPs, challenges
need to be addressed for the biomedical applications of
magnetothermal effects of MNPs in biological systems. Although local
thermal effect is very appealing for the next generation of magnetic car-
riers, these systems still need more investigations toward the under-
standing of very specific effects. Similarly, the “hot-spot” effect has
been explored and its effect was deduced indirectly from macroscopic
measurements, yet the local temperature profile around the nanoparti-
cles still requires to be fully documented andunderstood. In brief, differ-
ent approaches were conducted to demonstrate first indirect effects of
the local heating process. Then, measurements were achievedwith var-
ious probes to provide the temperature gradient at the surface of MNPs,
at different spatial resolution. However, experiments that could give the
temperature gradient from the MNPs surface to far apart (few hundred
nanometers) are still missing. There also remains plenty to be done
concerning themodeling of the nanoscale temperature gradient to con-
front experimental data depending both on the nature of magnetic
particles (free processing or Brownian rotation) and on magnetic stim-
ulation conditions. It would also be quite interesting to measure the
nanoscale thermal effect under MHT coupled to methods as dynamic
light scattering where the scattering coefficient could indicate the
local variation of temperature around nano-antennas [148].
Macromolecular polymers are flexible and efficient nanoplatforms
for drug encapsulation and delivery compared to inorganic nanoparti-
cles. However, despite the large portfolio of thermoresponsive nanosys-
tems tested in vitro, only few studies have demonstrated the efficacy of
AMF for in vivo drug release. Moreover, the mechanism of molecule re-
lease can be very complex. Understanding the diffusion of molecules
through the matrix, swelling of the matrix and the chemical reactivity
between the molecules and polymer chains (formation of hydrogen
bonds, or electrostatic interactions) would be necessary to modulate
and regulate the amount of drug released by such platforms [149–151].
On the level of MIPs for drug delivery applications, since the devices
are used in an aqueous environment, it would be generally preferable to
carry out the imprinting in water. Practical demonstrations of imprint-
ing in water have thus been rather limited to date. Among the best ex-
amples of molecular imprinting in aqueous environment are those
following the studies of Tanaka et al. [152]. Similar approaches can
thus be adopted in the design of MIPs to be used in biological media.
In addition, biodegradable polymers, and the potential for biodegrad-
able MIPs, would provide further flexibility in polymer morphology
and the resulting dosage form.
It is also desirable to control pore size and volume in these cross-
linked gels, perhaps in a way that allows the pores to be opened and
closed in response to a local change.
Concerning the global efficacy of thermal treatments, it should be
noted that, while a great number of reports have considered the modu-
lation of themagnetic properties for increasingMHT through the design
and synthesis of MNPs, recently, MNPs have also been envisaged as
promising agents for photothermal therapy [153–155].
Besides, Espinosa et al. [140] have demonstrated the amplification of
heating efficiency by MHT and PTT bimodal treatment using magnetite
iron oxide nanocubes. Further understanding of the mechanisms be-
hind the heating and the design of stable magnetite NPs toward oxida-
tion may allow to enlarge the panel of applications.Gold based magnetoplasmonic materials seem also a promising ap-
proach and alternative to hurdle the limitations of MHT. However, to
date their applications are still limited to the NIR-I windowwhere scat-
tering is strong in biological media. Semiconductor and plasmonic
nanoparticles such as substoichiometric copper sulfide compounds
(Cu2-xS) may represent concurrent candidates for efficient PTT, as well
as photo-acoustic imaging with deep penetration [156]. Compared to
available gold nanoparticles with dimensions suitable for biomedical
applications, Cu2-xS semiconductor nanomaterials exhibit fine-tune lo-
calized surface plasmon resonance and large extinction coefficients in
the second NIR biological window (NIR-II). In this region the imaging
resolution (signal-to-noise ratio) is high and light has its maximum
depth of penetration in tissues due to the reduction in the intensity of
auto fluorescence and the absorption/scattering of photons [157] .
Moreover, copper sulfide is biodegradable and its synthesis cost is
much cheaper than gold (1 mol of CuS is US $330, and 1 mol of Au
costs US $52,200) [158] , which is an important criteria for clinical trans-
lation and long-term applications. Such plasmonic semiconductors may
also allow to combine other modalities on the same nanohybrid for
multitherapy such as photodynamic therapy (PDT) while decreasing
the dose in NPs.References
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